Andrew Witty may not be ceo yet - that doesn’t happen until May 22 - but he’s already announcing senior management changes. The biggest move involves creating what he calls an emerging markets division to encompass activities in places such as Russia, China, India, Brazil and the Middle East. The unit that will be headed by Abbas Hussain, who spent 20 years at Lilly (pictured to the left).

At the same time, Witty is shuffling other divisions - the North America division now includes the US, Canada and Puerto Rico, and will be run by Chris Viehbacher, who heads the US pharma unit. A new Asia/Pacific region is being created to include Japan and Australia, and will be headed by Marc Dunoyer, who has headed the Japanese division. And Bob Ingram is no longer listed as a vice chairman. (Here’s the old line-up).

However, there is an opening for senior vp and general counsel. So if you know anyone…